MIF, a potential therapeutic target for rheumatoid arthritis?

Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity

(2014) Kuninobu Wakabayashi et al.   Modern Rheumatology

Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis

(2013) M.A. Llamas-Covarrubias et al.   CYTOKINE

Anti-TNF Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by Which Anti-TNF Might Reduce Inflammation

(2013) Marieke M. J. Herenius et al.   PLoS One

Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis

(2013) Anjana Singh et al.   RHEUMATOLOGY INTERNATIONAL

Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis

(2012) Ruiping Liu et al.   MOLECULAR BIOLOGY REPORTS

Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course

(2011) Mara Anaís Llamas-Covarrubias et al.   RHEUMATOLOGY INTERNATIONAL

Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis

(2011) Hae-Rim Kim et al.   ARTHRITIS RESEARCH & THERAPY